ETERNITY HEALTHCARE INC.: 10-Q filed 2015-12-08
What ETERNITY HEALTHCARE INC. reported in its quarterly report filed 2015-12-08 (fiscal Q2 2016): 24 published measures, 63 facts as tagged in accession 0001213900-15-009342.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-12-08
- Fiscal period
- fiscal Q2 2016
- Accession
- 0001213900-15-009342 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ETERNITY HEALTHCARE INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 1,050,289 | USD | |
| At 2015-04-30 | 955,052 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 1,321,831 | USD | |
| At 2015-04-30 | 1,072,216 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | -271,542 | USD | |
| At 2015-04-30 | -117,164 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 561,106 | USD | |
| At 2015-04-30 | 414,147 | USD | |
| At 2014-10-31 | 464,649 | USD | |
| At 2014-04-30 | 403,603 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | -101,169 | USD | 92 |
| 2015-05-01 to 2015-10-31 | -180,201 | USD | 184 |
| 2014-08-01 to 2014-10-31 | -126,808 | USD | 92 |
| 2014-05-01 to 2014-10-31 | -250,098 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-10-31 | -138,659 | USD | 184 |
| 2014-05-01 to 2014-10-31 | -152,892 | USD | 184 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | 25,394 | USD | 92 |
| 2015-05-01 to 2015-10-31 | 31,688 | USD | 184 |
| 2014-08-01 to 2014-10-31 | 26,129 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 43,488 | USD | 184 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-10-31 | 309,737 | USD | 184 |
| 2014-05-01 to 2014-10-31 | 767,496 | USD | 184 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | -548,723 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | -1,902,401 | USD | |
| At 2015-04-30 | -1,722,200 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | 21,273 | USD | 184 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | -89,505 | USD | 92 |
| 2015-05-01 to 2015-10-31 | -158,121 | USD | 184 |
| 2014-08-01 to 2014-10-31 | -128,352 | USD | 92 |
| 2014-05-01 to 2014-10-31 | -251,662 | USD | 184 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | 12,456 | USD | 92 |
| 2015-05-01 to 2015-10-31 | 24,413 | USD | 184 |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 1,166 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | 104,609 | USD | 92 |
| 2015-05-01 to 2015-10-31 | 176,924 | USD | 184 |
| 2014-08-01 to 2014-10-31 | 144,847 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 279,868 | USD | 184 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 23,928 | USD | |
| At 2015-04-30 | 33,710 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | 15,104 | USD | 92 |
| 2015-05-01 to 2015-10-31 | 18,803 | USD | 184 |
| 2014-08-01 to 2014-10-31 | 16,495 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 28,206 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | 33,050 | USD | 92 |
| 2015-05-01 to 2015-10-31 | 33,050 | USD | 184 |
| 2014-08-01 to 2014-10-31 | 7,400 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 7,400 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 66,429,868 | shares | |
| At 2015-04-30 | 66,429,868 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 1,539,591 | USD | |
| At 2015-04-30 | 1,539,591 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-10-31 | 24,838 | USD | |
| At 2015-04-30 | -985 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | 23,879 | USD | 92 |
| 2015-05-01 to 2015-10-31 | 51,295 | USD | 184 |
| 2014-08-01 to 2014-10-31 | 24,724 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 59,487 | USD | 184 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2015-10-31 | -11,664 | USD | 92 |
| 2015-05-01 to 2015-10-31 | -22,080 | USD | 184 |
| 2014-08-01 to 2014-10-31 | 1,544 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 1,564 | USD | 184 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-10-31 | -4,763 | USD | 184 |
| 2014-05-01 to 2014-10-31 | 1,497 | USD | 184 |
Inspect the source
- Entity
- ETERNITY HEALTHCARE INC. / CIK 0001437822
- Captured
- SEC response SHA-256
35d5bef516124e2db5b4e453c5629c1c21f903d8cbf34c16cb85424604a332ea
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001437822.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))